Whittier Trust’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-718
Closed -$50K 1616
2024
Q3
$50K Hold
718
﹤0.01% 926
2024
Q2
$48.3K Sell
718
-424
-37% -$28.6K ﹤0.01% 919
2024
Q1
$78.8K Buy
1,142
+424
+59% +$28.6K ﹤0.01% 839
2023
Q4
$44.7K Hold
718
﹤0.01% 942
2023
Q3
$40.3K Hold
718
﹤0.01% 967
2023
Q2
$36.2K Hold
718
﹤0.01% 998
2023
Q1
$39.2K Hold
718
﹤0.01% 1011
2022
Q4
$44.9K Hold
718
﹤0.01% 985
2022
Q3
$51K Hold
718
﹤0.01% 963
2022
Q2
$41K Hold
718
﹤0.01% 999
2022
Q1
$45K Hold
718
﹤0.01% 1001
2021
Q4
$40K Hold
718
﹤0.01% 1031
2021
Q3
$47K Hold
718
﹤0.01% 952
2021
Q2
$46K Buy
+718
New +$42.4K ﹤0.01% 974

Other funds holding AXNX

Whittier Trust's AXNX Position: Q4 2024 in Review

Whittier Trust sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 718 shares — an estimated $50K sold.

Whittier Trust first reported a position in AXNX in Q2 2021 and held it in 14 quarters. The position peaked at $78.8K in Q1 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Whittier Trust reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Whittier Trust sold 718 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $50K.
  • Whittier Trust first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 14 quarters.
  • Whittier Trust's Axonics, Inc. Common Stock position peaked at $78.8K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Whittier Trust's 13F filing for Q4 2024, filed 11 Feb 2025.